Skip to main content
SpringerLink
Log in

Discovery and Development of GG745, a Potent Inhibitor of Both Isozymes of of 5α-Reductase

  • Chapter
Integration of Pharmaceutical Discovery and Development

Part of the book series: Pharmaceutical Biotechnology ((PBIO,volume 11))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Andersson, S., and Russell, D. W., 1990, Structural and biochemical properties of cloned and expressed human and rat steroid 5α-reductases, Proc. Null. Acad. Sci. USA 87:3640–3644.

    CAS  Google Scholar 

  • Andersson, S., Bishop, R. W., and Russell, D. W., 1989, Expression cloning and regulation of steroid, 5α-reductase, an enzyme essential for male sexual differentiation, J. Biol. Chem. 264:16249–16255.

    CAS  PubMed  Google Scholar 

  • Andersson, S., Berman, D. M., Jenkins, E. P., and Russell, D. W., 1991, Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditism, Nature 354:159–161.

    Article  CAS  PubMed  Google Scholar 

  • Arrighi, H. M., Metter, E. J., Guess, H. A., and Fozzard, J. L., 1991, Natural history of benign prostatic hyperplasia and risk of prostatectomy, Urology Suppl. 38:4–8.

    CAS  Google Scholar 

  • Bakshi, R. K., Rasmusson, G. H., Patel, G. F, Mosley, R. T., Chang, B., Ellsworth, K., Harris, G. S., and Tolman, R. L., 1995, 4-Aza-3-oxo-5α-androsi-1-ene-17β-N-aryl-carboxamides as dual inhibitors of human type 1 and 2 steroid 5α-reductase Dramatic effect of N-aryl substituents on type I and type 2 5α-reductase inhibitory potency, J. Med. Chem. 38:3189–3192.

    Article  CAS  PubMed  Google Scholar 

  • Barry, M. J., Cockett, A. T. K., Holtgrewe, H. L., McConnell, J. D., Sihelnik, S. A., and Winfield, H. N., 1993, Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia, J. Urol. 150:351–358.

    CAS  PubMed  Google Scholar 

  • Boxenbaum, H., 1982, Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics, J. Pharmacokinet. Biopharm. 10(2):201–227.

    Article  CAS  PubMed  Google Scholar 

  • Brandt, M., and Levy, M. A., 1989, 3β-Hydroxy-Δ5-steroid dehydrogenase / 3-keto- Δ5-steroid isomerasefrombovineadrenals: Mechanism of inhibition by 3-oxa-4-azasteroids and kinetic mechanism of the dehydrogenase, Biochemistry 28:140–148.

    CAS  PubMed  Google Scholar 

  • Brawley, O. W., Ford, L. G., Thompson, I., Perlman, J. A., and Kramer, B. S., 1994, 5α-reductase inhibition and prostate cancer prevention, Cancer Epidemiol. Biomarker Prev. 3:177–182.

    CAS  Google Scholar 

  • Brooks, J. R., 1986, Treatment of hirsutism with 5α-reductase inhibitors, Clin. Endocrinol. Metab. 15:391–405.

    Article  CAS  PubMed  Google Scholar 

  • Bull, H. G., Garcia-Calvo, M., Anderson, S., Baginsky, W. F., Chan, H. K., Ellsworth, D. E., Miller, R. R., Stearns, R. A., Bakshi, R. K., Rasmusson, G. H., Tolman, R. L., Myers, R. W., Kozarich, J. W., and Harris, G. S., 1996, Mechanism-based inhibition of human steroid 5α-reductase by finasteride: Enzyme-catalyzed formation of NADP-dihydrofinasteride, a potent bisubstrate analog inhibitor, J. Am. Chem. Soc. 118:2359–2365.

    Article  CAS  Google Scholar 

  • Carlin, J. R., Christofalo, P., Arison, B. H., VandenHeuvel, W. J. A., Miller, R. R., Ellsworth, R. L., and Chiu, S.-H. L., 1992a, The disposition and pharmacokinetics of finasteride in the dog, ISSX Proc. 2:197.

    Google Scholar 

  • Carlin, J. R., Hoglund, P., Eriksson, L.-O., Christofalo, P., Gregoire, S. L., Taylor, A. M., and Anderson, K.-E., 1992b, Disposition and pharmacokinetics of [14C]-finasteride after oral administration in humans, Drug Metab. Dispos. 20:148–155.

    CAS  PubMed  Google Scholar 

  • Chan, W. K., Fong, C. Y., Tiong, H. H., and Tan, C. H., 1987, The inhibition of 3βHSD activity in porcine granulosa cells by 4-MA, a potent 5α-reductase inhibitor, Biochem. Biophys. Res. Commun. 144:166–171.

    Article  CAS  PubMed  Google Scholar 

  • Cooke, G. M., and Robaire, B. J., 1986, The effects of diethyl-4-methyl-3-oxo-4-aza-5α-androstane-17β-carboxamide (4MA) and (4R)-5,10-seco-19-norpregna-4,5-diene-3, 10,20-trione (SECO) on androgen biosynthesis in the rat testis and epididymis, Steroid Biochem. 24:877–886.

    CAS  Google Scholar 

  • Dallob, A. L., Sadick, N. S., Unger, W., Lipert, S., Geissler, L. A., Gregoire, S. L., Nguyen, H. H., Moore, E. C., and Tanaka, W. K., 1994, The effect of finasteride, a 5α-reductase inhibitor, on scaip on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness, J. Clin. Endocrinol. Metab. 79:703–706.

    Article  CAS  PubMed  Google Scholar 

  • Darley, C. R., 1984, Recent advances in hormonal aspects of acne vulgaris. Int. J. Dermatol. 23:539–541.

    CAS  PubMed  Google Scholar 

  • Denis, L., and Mahler, C., 1990, Prostatic cancer: An overview, Rev. Oncol. 3:665–677.

    Google Scholar 

  • De Schepper, P. J., Imperato-McGinley, J., Van Hecken, A., De Lepeleire, I., Buntinx, A., Carlin, J., Gressi, M. H., and Stoner, E., 1991, Hormonal effects, tolerability, and preliminary kinetics in men of MK-906, a 5α-reductase inhibitor Steroids 56:469–471.

    PubMed  Google Scholar 

  • Diani, A. R., Mulholland, M. J., Shull, K. L., Kubicek, M. F., Johnson, G. A., Schostarez, H. J., Brunden, M. N., and Buhl, A. E., 1992, Hair growth effects of oral administration of finasteride, a steroid inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque, J. Clin. Endocrinol. Metab. 74:345–350.

    Article  CAS  PubMed  Google Scholar 

  • Faller, B., Farley, D., and Nick, H., 1993, Finasteride: A slow-binding 5α-reductase inhibitor, Biochemistry 32:5705–5710.

    CAS  PubMed  Google Scholar 

  • Frye, S. V., 1996, Inhibitors of 5α-reductase, Curr. Pharm. Des. 2:59–84.

    CAS  Google Scholar 

  • Frye, S. V., Haffner, C. D., Maloney, P. R., Mook, R. A., Jr., Dorsey G. F., Jr., Hiner, R. N., Batchelor, K. W., Bramson, H. N., Stuart, J. D., Schweiker, S. L., van Arnold, J., Bickett, D. M., Moss, M. L., Tian, G., Unwalla, R. J., Lee, F. W., Tippin, T. K., James, M. K., Grizzle, M. K., Long, J. E., and Schuster, S. V., 1993, 6-Azasteroids: Potent dual inhibitors of human type 1 and 2 steroid 5α-reductase. J. Med. Chem. 36:4313–4315.

    CAS  PubMed  Google Scholar 

  • Frye, S. V, Haffner, C. D., Maloney, P. R., Mook, R. A., Jr., Dorsey, G. F., Jr., Hiner, R. N., Cribbs, C. M., Wheeler, T. N., Ray, J. A., Andrews, R. C., Batchelor, K. W., Bramson, H. N., Stuart, J. D., Schweiker, S. L., van Arnold, J., Croom, S., Bickett, D. M., Moss, M. L., Tian, G., Unwalla, R. J., Lee, F. W., Tippin, T. K., James, M. K., Grizzle, M. K., Long, J. E., and Schuster, S. V., 1994, 6-Azasteroids: Structure activity relationships for inhibition of type 1 and 2 human 5α-reductase and human adrenal 3β-Hydroxy-Δ5-steroid dehydrogenase / 3-keto- Δ5-steroid isomerase J. Med. Chem. 37:2352–2360.

    Article  CAS  PubMed  Google Scholar 

  • Frye, S. V, Haffner, C. D., Maloney, P. R., Hiner, R. N., Dorsey, G. F., Jr., Noe, R. A., Unwalla, R. J., Batchelor, K. W., Bramson, H. N., Stuart, J. D., Schweiker, S. L., van Arnold, J., Bickett, D. M., Moss, M. L., Tian, G., Lee, F. W., Tippin, T. K., James, M. K., Grizzle, M. K., Long, J. E., and Croom, D. K., 1995, Structure-activity relationships for inhibition of type 1 and 2 human 5α-reductase and human adrenal 3β-Hydroxy-Δ5-steroid dehydrogenase / 3-keto- Δ5-steroid isomerase by 6-azaandrost-4-en-3-ones: Optimization of the C17 substituent, J. Med. Chem. 38:2621–2627.

    Article  CAS  PubMed  Google Scholar 

  • Geller, J., 1991, Benign prostatic hyperplasia: Pathogenesis and medical therapy, J. Am. Geriatr. Soc. 39:1208–1216.

    CAS  PubMed  Google Scholar 

  • Geller, J., 1993, Basis for hormonal management of advanced prostate cancer, Cancer Suppl. 71:1039–1045.

    CAS  Google Scholar 

  • Gormley, G. J., 1991, Role of inhibitors in the treatment of advanced prostatic carcinoma, Urol. Clin. N. Am. 18:93–98.

    CAS  Google Scholar 

  • Gormley, G. L., Stoner, E., Rittmaster, R. S., Gregg, H., Thompson, D. L., Lasseter, K. C., Vlasses, P. H., and Stein, E. A., 1990, Effects of finasteride (MK-906), a on circulating androgens in male volunteers, J. Clin. Endocrinol. Metab. 70:1136–1141.

    CAS  PubMed  Google Scholar 

  • Griffiths, K., Eaton, C. L., Harper, M. E., Peeling, B., and Davies, P., 1991, Steroid hormones and the pathogenesis of benign prostatic hyperplasia, Eur. Urol. 20:68–77.

    PubMed  Google Scholar 

  • Grino, P. B., Griffin, J. E., and Wilson, J. D., 1990, Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone, Endocrinology 126:1165–1172.

    CAS  PubMed  Google Scholar 

  • Imperato-McGinley, J., Guerrero, L., Gautier, T., and Peterson, R. E., 1974, Steroid 5α-reductase deficiency in man: An inherited form of male pseudohermaphroditism, Science 186:1213–1215.

    CAS  PubMed  Google Scholar 

  • Imperato-McGinley, J., Gautier, T., Zirinsky, K., Horn, T., Palomo, O., Stein, E., Vaughan, E. D., Markisz, J. A., Arellano, E. R., and Kazam, E., 1992, Prostate visualization studies in males homozygous and heterozygous for 5α-reductase, J. Clin. Endocrinol. Metab. 75:1022–1026.

    Article  CAS  PubMed  Google Scholar 

  • Imperato-McGinley, J., Gautier, T., Cai, L.-Q., Yee, B., Epstein, J., and Pochi, P., 1993, The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity, J. Clin. Endocrinol. Metab. 76:524–528.

    Article  CAS  PubMed  Google Scholar 

  • Ings, R. M. J., 1990, Interspecies scaling and comparisons in drugs development and toxicokinetics, Xenobiotica 20:1201–1231.

    CAS  PubMed  Google Scholar 

  • Isaacs, J. T, 1990, Importance of the natural history of benign prostatic hyperplasia in the evaluation of pharmacologic intervention, Prostate Suppl. 3:1–7.

    CAS  PubMed  Google Scholar 

  • Jenkins, E. P., Anderson, S., Imperato-McGinley, J., Wilson, J. D., and Russell, D. W., 1992, Genetic and pharmacological evidence for more than one human steroid 5α-reductase. J. Clin. Invest. 89:293–300.

    CAS  PubMed  Google Scholar 

  • Josso, N., 1994, Anatomy and endocrinology of fetal sex differentiation, in: Endocrinology, Volume 2 (L. J. DeGroot, ed.), pp. 1888–1900, Saunders, Philadelphia.

    Google Scholar 

  • Kreig, M., Nass, R., and Tunn, S., 1993, Effect of aging on endogenous level of testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate, J. Clin. Endocrinol. Metab. 77:375–381.

    Google Scholar 

  • Lephart, E. D., 1993, Brain Cellular, enzymatic and molecular perspectives and implications for biological function, Mol. Cell. Neurosci. 4:473–484.

    CAS  Google Scholar 

  • Lephart, E. D., and Husmann, D. A., 1993, Altered brain and pituitary androgen metabolism by prenatal, perinatal or pre-and postnatal finasteride, flutamide or dihydrotestosterone treatment in juvenile male rats, Prog. Neuro-Psychopharmacol. Biol. Psychiatry 17:991–1003.

    Article  CAS  Google Scholar 

  • Lettré, H., and Knof, L., 1960, 6-Aza-cholesterol and derivatives, Chem. Ber. 93:2860–2864.

    Google Scholar 

  • Levine, A. C., Wang, J.-P, Ren, M., Eliashvilli, E., Russell, D. W., and Kirschenbaum, A., 1996, Immunohistochemical localization of steroid 5α-reductase 2 in human male fetal reproductive tract and adult prostate, J. Clin. Endocrinol. Metab. 81:384–389.

    Article  CAS  PubMed  Google Scholar 

  • Levy, M. A., Brandt, M., and Greway, A.T., 1990, Mechanistic studies with solubilized rat liver steroid 5α-reductase Elucidation of the kinetic mechanism, Biochemistry 29:2808–2815.

    CAS  PubMed  Google Scholar 

  • Liang, T., and Heiss, C. E., 1981, Inhibition of 5α-reductase, receptor binding, and nuclear uptake of androgens in the prostate by a 4-methyl-4-aza-steroid, J. Biol. Chem. 256:7998–8005.

    CAS  PubMed  Google Scholar 

  • Liang, T., Cascieri, M. A., Cheung, A. H., Reynolds, G. F., and Rasmusson, G. H., 1985, Species differences in prostatic steroid 5α-reductase of rat, dog, and human, Endocrinology 117:571–579.

    CAS  PubMed  Google Scholar 

  • Martini, L., 1982, The 5α-reductase of testosterone in the neuroendocrine structures. Biochemical and physiological implications, Endocr. Rev. 3:1–25.

    CAS  PubMed  Google Scholar 

  • Martini, L., and Melcangi, R. C., 1991, Androgen metabolism in the brain, J. Steroid Biochem. Mol. Biol. 39:819–828.

    Article  CAS  PubMed  Google Scholar 

  • McConnell, J. D., 1990, Androgen ablation and blockade in the treatment of benign prostatic hyperplasia, Urol. Cin. North Am. 17:661–670.

    CAS  Google Scholar 

  • Melcangi, R. C., Celotti, F., and Martini, L., 1994, Progesterone 5-α-reduction in neuronal and in different types of glial cell cultures: Type 1 and 2 astrocytes and oligodendrocytes, Brain Res. 639:202–206.

    Article  CAS  PubMed  Google Scholar 

  • Mocellini, A. I., Gardiner, R., Marshall, V., Johnson, W., Bartsch, G., Schmidbauer, C. P., Mossing, H., Van Cangh, P. J., Denis, L. J., Arap, S., Freire, G. C., De Latorre, D., Botto, H., Richard, F., Devonec, M., Teillac, P., Vallancien, G., Bzaf, Z., DiSilverio, F., Miano, L., Pagano, F, Gabilondo, F., DeBuyne, F., Janknegt, R. A., Schroeder, F. H., Nacey, J., Furtado, L. A., Carretero, P., Jimenez, F. C., Hauri, D., Otto, U., Albrecht, J., Altwein, J. E., Egghart, G., Engelmann, U., Jacobi, G. H., Kreyes, G., Panijel, M., Riedasch, G., Rugendorff, E. W., Fabricius, P., O’Boyle, P. J., Gingell, C., Buck, A. C., Charig, C., Grino, P., Ferguson, D., Round, E., Shih, J., and Stoner, E., 1993, Finasteride (MK-906) in the treatment of benign prostatic hyperplasia, Prostate 22:291–299.

    Google Scholar 

  • Moore, R. A., 1944, Benign hypertrophy and carcinoma of the prostate, occurrence and experimental production in animals. Surgery 16:152.

    Google Scholar 

  • Mordenti, J., 1986, Man versus beast: Pharmacokinetic scaling in mammals, J. Pharm. Sci. 75:1028–1040.

    CAS  PubMed  Google Scholar 

  • Morris, D. M., Grosse, C. M., and Selinger, K. A., 1995, Determination of GI198745 in human serum by LC/APCI/MS, Abstract, The 6th International Symposium for Pharmaceutical and Biomedical Analysis, St. Louis, M-P/A9.

    Google Scholar 

  • Ohtawa, M., Morikawa, H., and Shimazaki, J., 1991, Pharmacokinetics and biochemical efficacy after single and multiple oral administration of N-(2-methyl-2-propy)-3-oxo-4-aza-5α-androst-I-ene-17β-carhoxamide, a new type of specific competitive inhibitor of testosterone 5α-reductase, in volunteers, Eur. J. Drug Metab. Pharmacokin. 16:15–21.

    CAS  Google Scholar 

  • Pérez-Palacios, G., Larsson, K., and Beyer, C., 1975, Biological significance of the metabolism of androgens in the central nervous system, J. Steroid Biochem. 6:999–1006.

    PubMed  Google Scholar 

  • Perron, S., and Bélanger, A., 1994, Effects of 4MA, a potent inhibitor of 5α-reductase, on 3β-hydroxysteroid dehydrogenase / Δ5 − Δ4 -isomerase activity in guinea pig adrenals, Steroids 59:371–376.

    Article  CAS  PubMed  Google Scholar 

  • Peters, D. H., and Sorkin, E. M., 1993, Finasteride: A review of its potential in the treatment of benign prostatic hyperplasia, Drugs 46:177–208.

    CAS  PubMed  Google Scholar 

  • Petrow, V., and Padilla, G. M., 1984, 5α-reductase A target enzyme for prostatic cancer, in: Novel Approaches to Cancer Chemotherapy (P. S. Sunkara, ed.), pp. 269–305, Academic Press, Orlando.

    Google Scholar 

  • Potts, G. O., Creange, J. E., Harding, H. R., and Schane, H. P., 1978, Trilostane, an orally active inhibitor of steroid biosynthesis, Steroids 32:257–267.

    Article  CAS  PubMed  Google Scholar 

  • Presti, J. C., Fair, W. R., Andriole, G., Sogani, P. C., Seidmon, E. J., Ferguson, D., Ng, J., and Gormley, G. J., 1992, Multicenter, randomized, double-blind, placebo controlled study to investigate the effect of finasteride (MK-906) on stage D prostate cancer, J. Urol. 148:1201–1204.

    PubMed  Google Scholar 

  • Price, V. H., 1975, Testosterone metabolism in the skin, Arch. Dermatol. 111:1496–1502.

    Article  CAS  PubMed  Google Scholar 

  • Rasmusson, G. H., Reynolds, G. F., Utne, T., Jobson, R. B., Primka, R. L., Berman, C., and Brooks, J. R., 1984, Azasteroids as inhibitors of rat prostatic 5α-reductase, J. Med. Chem. 27:1690–1701.

    Article  CAS  PubMed  Google Scholar 

  • Rasmusson, G, H., Reynolds, G. F., Steinberg, N. G., Walton, E., Patel, G. F., Liang, T., Cascieri, M. A., Cheung, A. H., Brooks, J. R., and Berman, C., 1986, Azasferoids: Structure-activity relationships for inhibition of 5α-reductase and of androgen receptor binding, J. Med. Chem. 29:2298–2314.

    Article  CAS  PubMed  Google Scholar 

  • Ritschel, W. A., Vachharajani, N. N., Johnson, R. D., and Hussain, A. S., 1992, The allometric approach for interspecies scaling of pharmacokinetic parameters, Comp. Biochem. Physiol. C Comp. Pharmacol. Toxicol. 103C:249–253.

    CAS  Google Scholar 

  • Rittmaster, R. S., 1994, Finasteride, N. Engl. J. Med. 330:120–125.

    Article  CAS  PubMed  Google Scholar 

  • Russell, D. W., and Wilson, J. D., 1994, Steroid 5α-reductase; Two genes/two enzymes, Annu. Rev. Biochem. 63:25–61.

    CAS  PubMed  Google Scholar 

  • Schweikert, H. U., and Wilson, J. D., 1974, Regulation of human hair growth by steroid hormones. I. Testosterone metabolism in isolated hairs, J. Clin. Endocrinol. Metab. 38:811–819.

    CAS  PubMed  Google Scholar 

  • Shapiro, E., Becich, M. J., Hartanto, V., and Lepor, H., 1992, The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostatic hyperplasia, J. Urol. 147:1293–1297.

    CAS  PubMed  Google Scholar 

  • Siiteri, P. K., and Wilson, J. D., 1974, Testosterone formation and metabolism during male sexual differentiation in the human embryo, J. Clin. Endocrinol. Metab. 38:113–125.

    CAS  PubMed  Google Scholar 

  • Stoner, E., 1994. Maintenance of clinical efficacy with finasteride therapy for 24 months in patients with benign prostatic hyperplasia, Arch. Intern. Med. 154:83–88.

    Article  CAS  PubMed  Google Scholar 

  • Sudduth, S. L., and Koronkowski, M. J., 1993, Finasteride: The first 5α-reductase inhibitor, Pharmacotherupy 13:309–329.

    CAS  Google Scholar 

  • Tenover, J. S., 1991, Prostates, pates and pimples: The potential medical uses of steroid 5α-reductase inhibitors, Endocrinol. Metab. Clin. North Am. 20:893–909.

    CAS  PubMed  Google Scholar 

  • Thigpen, A. E., Davis, D. L., Milatovich, A., Mendonca, B. B., Imperato-McGinley, J., Griffin, J. E., Francke, U., Wilson, J. D., and Russell, D. W., 1992, Molecular genetics of steroid 5α-reductase 2 deficiency, J. Clin. Invest. 90:799–809.

    CAS  PubMed  Google Scholar 

  • Thigpen, A. E., Silver, R. I., Guileyardo, J. M., Casey, M. L., McConnell, J. D., and Russell, D. W., 1993, Tissue distribution and ontogeny of steroid 5α-reductase isozyme expression, J. Clin. Invest. 92:903–910.

    CAS  PubMed  Google Scholar 

  • Tian, G. J., 1996, In vivo time-dependent inhibition of human steroid 5α-reductase by finasteride, Pharm. Sci. 85:106–111.

    CAS  Google Scholar 

  • Tian, G., Stuart, J. D., Moss, M. L., Domanico, P. L., Bramson, H. N., Patel, I. R., Kadwell, S. H., Overton, L. K., Kost, T. A., Mook, R. A., Jr., Frye, S. V, Batchelor, K. W., and Wiseman, J. S., 1994, 17β-(N-tert-butylcarbamoyl)-4-aza-5α-androstan-1-en-3-one is an active site-directed slow time-dependent inhibitor of human steroid 5-alpha-reductase, Biochemistry 33:2291–2296.

    CAS  PubMed  Google Scholar 

  • Tian, G., Mook, R. A., Jr., Moss, M. L., and Frye, S. V., 1995a, Mechanism of time-dependent inhibition of 5-alpha-reductases by Δ1-4-azazteroids: Toward perfection of rates of time-dependent inhibition by using ligand-binding energies, Biochemistry 34:13453–13459.

    Article  CAS  PubMed  Google Scholar 

  • Tian, G., Chen, S.-Y., Facchine, K. L., and Prakash, S. R., 1995b, Chemical mechanism of the covalent modification of 5α-reductase by finasteride as probed by secondary tritium isotope effects, J. Am. Chem. Soc. 117:2369–2370.

    CAS  Google Scholar 

  • Tippin, T. K., Sinhababu, A. K., Lee. F. W., Haffner, C., Maloney, P., Hiner, R. and Frye, S. V., 1995, Application of microsomal metabolism rates to identify 6-azasteroidal 5α-reductase inhibitors with optium in vivo half-life, ISSX Proc. 8:46.

    Google Scholar 

  • Vermeulen, A., Giagulli, V. A., De Schepper, P., Buntinx, A., and Stoner, E., 1989, Hormonal effects of an orally active 4-azasteroid inhibitor of 5α-reductase in humans, Prostate 14:45–53.

    CAS  PubMed  Google Scholar 

  • Vermeulen, A., Giagulli, V. A., De Schepper, P. J., and Buntinx, A., 1991, Hormonal effects of a 5α-reductase reductase inhibitor (finasteride) on hormonal levels in normal men and in patients with benign prostatic hyperplasia, Eur. Urol. 20:82–86.

    PubMed  Google Scholar 

  • Walsh, P. C., Madden, J. D., Harrod, M. J., Goldstein, J. L., MacDonald, P. C., and Wilson, J. D., 1974, Familial incomplete mate pseudohermaphroditism, type 2. Decreased dihydro-testosterone formation in pseudovaginal perineoscrotal hypospadias, N. Engl. J. Med. 291:944–949.

    CAS  PubMed  Google Scholar 

  • Wilson, J. D., 1989, Sexual differentiation of the gonads and of the reproductive tract, Biol. Neonate 55:322–330.

    CAS  PubMed  Google Scholar 

  • Wolfenden, R., 1972, Analog approaches to the structures of the transition state in enzyme reactions, Acc. Chem. Res. 5:10–18.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Glaxo Wellcome Research and Development, Research Triangle Park, North Carolina, 27709

    Stephen V. Frye, H. Neal Bramson, David J. Hermann, Frank W. Lee, Achintya K. Sinhababu & Gaochao Tian

Authors
  1. Stephen V. Frye
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Neal Bramson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David J. Hermann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Frank W. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Achintya K. Sinhababu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gaochao Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The University of Kansas, Lawrence, Kansas

    Ronald T. Borchardt

  2. Merck Research Laboratories, West Point, Pennsylvania

    Roger M. Freidinger

  3. ARIAD Pharmaceuticals, Inc., Cambridge, Massachusetts

    Tomi K. Sawyer

  4. Smith Kline Beecham, Collegeville, Pennsylvania

    Philip L. Smith

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Frye, S.V., Bramson, H.N., Hermann, D.J., Lee, F.W., Sinhababu, A.K., Tian, G. (2002). Discovery and Development of GG745, a Potent Inhibitor of Both Isozymes of of 5α-Reductase. In: Borchardt, R.T., Freidinger, R.M., Sawyer, T.K., Smith, P.L. (eds) Integration of Pharmaceutical Discovery and Development. Pharmaceutical Biotechnology, vol 11. Springer, Boston, MA. https://doi.org/10.1007/0-306-47384-4_17

Download citation

  • DOI: https://doi.org/10.1007/0-306-47384-4_17

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-45743-2

  • Online ISBN: 978-0-306-47384-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation